Price loading...

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in China

Price data last checked 104 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
16 August 2022
Listed Since
24 August 2022

Similar Products You Might Like

The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in China
99% match

The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in China

£495.00 24 Jan 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in China
99% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma in China

£495.00 19 Apr 2026
The 2023-2028 Outlook for Lymphoma Treatments in China
99% match

The 2023-2028 Outlook for Lymphoma Treatments in China

£495.00 23 Jan 2026
The 2023-2028 Outlook for Multiple Myeloma Treatments in China
98% match

The 2023-2028 Outlook for Multiple Myeloma Treatments in China

£495.00 25 Jan 2026
The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in China
97% match

The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in China

£495.00 20 Jan 2026
The 2023-2028 Outlook for Bile Duct Cancer (Cholangiocarcinoma) Treatments in China
97% match

The 2023-2028 Outlook for Bile Duct Cancer (Cholangiocarcinoma) Treatments in China

£495.00 25 Jan 2026
The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in China
97% match

The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in China

£495.00 11 Jan 2026
The 2023-2028 Outlook for Basal Cell Carcinoma Treatments in China
97% match

The 2023-2028 Outlook for Basal Cell Carcinoma Treatments in China

£495.00 08 Jan 2026
The 2023-2028 Outlook for Natural Killer Cell Therapeutics in China
97% match

The 2023-2028 Outlook for Natural Killer Cell Therapeutics in China

£495.00 12 Jan 2026
The 2023-2028 Outlook for Cervical Cancer Treatments in China
97% match

The 2023-2028 Outlook for Cervical Cancer Treatments in China

£495.00 25 Jan 2026
The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in China
97% match

The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in China

£495.00 12 Mar 2026
The 2023-2028 Outlook for Triple-Negative Breast Cancer Treatments in China
97% match

The 2023-2028 Outlook for Triple-Negative Breast Cancer Treatments in China

£495.00 12 Jan 2026
Endometrial Cancer Treatments in China 2023-2028 Outlook
97% match

Endometrial Cancer Treatments in China 2023-2028 Outlook

£495.00 04 Apr 2026
The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in China
97% match

The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in China

£495.00 07 Jan 2026
The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in China
96% match

The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in China

£495.00 20 Jan 2026
The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in China
96% match

The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in China

£495.00 09 Jan 2026
The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in China
96% match

The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in China

£495.00 20 Mar 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in China
96% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in China

£495.00 08 Mar 2026
The 2023-2028 Outlook for Cancer Screenings in China
96% match

The 2023-2028 Outlook for Cancer Screenings in China

£495.00 16 Dec 2025
The 2023-2028 Outlook for Head and Neck Oncology Nutrition in China
96% match

The 2023-2028 Outlook for Head and Neck Oncology Nutrition in China

£495.00 20 Mar 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in Japan
96% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in Japan

£495.00 24 Jan 2026
The 2023-2028 Outlook for Oncolytic Virus Immunotherapies in China
96% match

The 2023-2028 Outlook for Oncolytic Virus Immunotherapies in China

£495.00 11 Jan 2026
The 2023-2028 Outlook for HPV and CMV Therapeutics in China
96% match

The 2023-2028 Outlook for HPV and CMV Therapeutics in China

£495.00 16 Dec 2025
The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in Japan
96% match

The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in Japan

£495.00 22 Jan 2026